transplant rejection

Feb 25, 2022

Thermo Fisher Scientific Deal Expands Possibilities for Exosome Dx Business, Bio-Techne CEO Says
Premium

Feb 22, 2022

Bio-Techne, Thermo Fisher Scientific to Further Develop, Commercialize Kidney Transplant Rejection Assay

Feb 2, 2022

Cell-Free DNA Assay Shows Promise for Detecting Stem Cell Transplant Complications
Premium

Jan 24, 2022

SQI Diagnostics, Owlstone Medical Ink MOU for Lung Infection, Transplant Rejection

Dec 23, 2021

Oncocyte Switches Gears on Transplant Test Commercialization, Plans to Launch LDT Next Year
Premium

Dec 13, 2021

CareDx to Study AlloSure Kidney for Routine Organ Transplant Surveillance in Pediatric Patients

Nov 5, 2021

Natera Aiming to Translate Success in Colorectal Cancer Diagnostics Into Other Areas
Premium

Oct 29, 2021

CareDx Works Toward Goal of Becoming Essential Transplant Diagnostics Company
Premium

Sep 29, 2021

CareDx Patents Deemed Invalid in Court Battle Against Natera, Eurofins Viracor

Aug 11, 2021

Oncocyte Updates Plans for Chronix Transplant Tech; Will Develop and Market Kits in Europe
Premium

May 6, 2021

Natera Q1 Revenues Grow 62 Percent

May 5, 2021

CareDx Q1 Revenues up 76 Percent

Apr 28, 2021

NY State Department of Health Approves Eurofins Viracor Transplant Rejection Tests

Mar 19, 2021

NephroSant Readies Launch of Kidney Transplant Rejection Assay
Premium

Mar 17, 2021

CareDx Acquires European Transplant Surveillance Software Firm BFS Molecular

Mar 16, 2021

NephroSant Raises $16M in Series A Funding Round

Feb 26, 2021

GenDx HLA Genotyping Products Receives Health Canada IVD Approval

Feb 25, 2021

CareDx Expanding Diagnostic Tech Into Cell Transplant Monitoring
Premium

Feb 24, 2021

CareDx Q4 Revenues Up 64 Percent

Feb 8, 2021

Eurofins Viracor, Cleveland Clinic Sign License Deal for Kidney Transplant Rejection Biomarker Test